A Woodlands school has moved to the head of the class. Photo by Klaus Vedfelt/Getty Images

A Houston-area school earned top honors in Texas in U.S. News & World Report's first-ever ranking of the state's best elementary schools.

Creekside Forest Elementary School comes in at No. 10. Creekside is nestled in the bustling Woodlands and in the Tomball Independent School District.

A public school, Creekside Forest Elementary boasts student population of 571, serving serves kindergarten through fifth grade. Impressively, according to the report, 93 percent of students here scored at or above the proficient level for math, and 87 percent scored at or above that level for reading.

Notably, the student-teacher ratio is at Creekside is 16:1, which is better than that of the district. The school employs 36 equivalent full-time teachers and one full-time school counselor.

The student population at Creekside is made up of 49 percent female students and 51 percent male students, with minority student enrollment at 43 percent. One percent of students here at economically disadvantaged.

According to the school's website, Creekside "is a learning community where all continuously strive for excellence."

Unlike its annual list of the country's best high schools, U.S. News & World Report didn't come up with a national ranking of elementary schools. Rather, it published a ranking for each state.

Myriad other Houston-area schools land later on the list, including West University Elementary at No. 17. According to U.S. News, the 10 best elementary schools in Texas are:

  1. William B. Travis Academy/Vanguard for the Academically Talented and Gifted, Dallas ISD.
  2. Windsor Park G/T Elementary School, Corpus Christi ISD.
  3. Old Union Elementary School, Carroll ISD.
  4. Carroll Elementary School, Carroll ISD.
  5. Hudson Elementary School, Longview ISD.
  6. Sudie L. Williams Talented and Gifted Academy, Dallas ISD.
  7. Canyon Creek Elementary School, Round Rock ISD.
  8. Carver Center, Midland ISD.
  9. Cactus Ranch Elementary School, Round Rock ISD.
  10. Creekside Forest Elementary School, Tomball ISD.
------

This article originally ran on CultureMap.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Axiom Space-tested cancer drug advances to clinical trials

mission critical

A cancer-fighting drug tested aboard several Axiom Space missions is moving forward to clinical trials.

Rebecsinib, which targets a cancer cloning and immune evasion gene, ADAR1, has received FDA approval to enter clinical trials under active Investigational New Drug (IND) status, according to a news release. The drug was tested aboard Axiom Mission 2 (Ax-2) and Axiom Mission 3 (Ax-3). It was developed by Aspera Biomedicine, led by Dr. Catriona Jamieson, director of the UC San Diego Sanford Stem Cell Institute (SSCI).

The San Diego-based Aspera team and Houston-based Axiom partnered to allow Rebecsinib to be tested in microgravity. Tumors have been shown to grow more rapidly in microgravity and even mimic how aggressive cancers can develop in patients.

“In terms of tumor growth, we see a doubling in growth of these little mini-tumors in just 10 days,” Jamieson explained in the release.

Rebecsinib took part in the patient-derived tumor organoid testing aboard the International Space Station. Similar testing is planned to continue on Axiom Station, the company's commercial space station that's currently under development.

Additionally, the drug will be tested aboard Ax-4 under its active IND status, which was targeted to launch June 25.

“We anticipate that this monumental mission will inform the expanded development of the first ADAR1 inhibitory cancer stem cell targeting drug for a broad array of cancers," Jamieson added.

According to Axiom, the milestone represents the potential for commercial space collaborations.

“We’re proud to work with Aspera Biomedicines and the UC San Diego Sanford Stem Cell Institute, as together we have achieved a historic milestone, and we’re even more excited for what’s to come,” Tejpaul Bhatia, the new CEO of Axiom Space, said in the release. “This is how we crack the code of the space economy – uniting public and private partners to turn microgravity into a launchpad for breakthroughs.”

Chevron enters the lithium market with major Texas land acquisition

to market

Chevron U.S.A., a subsidiary of Houston-based energy company Chevron, has taken its first big step toward establishing a commercial-scale lithium business.

Chevron acquired leaseholds totaling about 125,000 acres in Northeast Texas and southwest Arkansas from TerraVolta Resources and East Texas Natural Resources. The acreage contains a high amount of lithium, which Chevron plans to extract from brines produced from the subsurface.

Lithium-ion batteries are used in an array of technologies, such as smartwatches, e-bikes, pacemakers, and batteries for electric vehicles, according to Chevron. The International Energy Agency estimates lithium demand could grow more than 400 percent by 2040.

“This acquisition represents a strategic investment to support energy manufacturing and expand U.S.-based critical mineral supplies,” Jeff Gustavson, president of Chevron New Energies, said in a news release. “Establishing domestic and resilient lithium supply chains is essential not only to maintaining U.S. energy leadership but also to meeting the growing demand from customers.”

Rania Yacoub, corporate business development manager at Chevron New Energies, said that amid heightening demand, lithium is “one of the world’s most sought-after natural resources.”

“Chevron is looking to help meet that demand and drive U.S. energy competitiveness by sourcing lithium domestically,” Yacoub said.

---

This article originally appeared on EnergyCapital.